Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Neurobiology and the Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Neurochem Int. 2024 Mar;174:105695. doi: 10.1016/j.neuint.2024.105695. Epub 2024 Feb 17.
The neuron-specific K/Cl co-transporter 2, KCC2, which is critical for brain development, regulates γ-aminobutyric acid-dependent inhibitory neurotransmission. Consistent with its function, mutations in KCC2 are linked to neurodevelopmental disorders, including epilepsy, schizophrenia, and autism. KCC2 possesses 12 transmembrane spans and forms an intertwined dimer. Based on its complex architecture and function, reduced cell surface expression and/or activity have been reported when select disease-associated mutations are present in the gene encoding the protein, SLC12A5. These data suggest that KCC2 might be inherently unstable, as seen for other complex polytopic ion channels, thus making it susceptible to cellular quality control pathways that degrade misfolded proteins. To test these hypotheses, we examined KCC2 stability and/or maturation in five model systems: yeast, HEK293 cells, primary rat neurons, and rat and human brain synaptosomes. Although studies in yeast revealed that KCC2 is selected for endoplasmic reticulum-associated degradation (ERAD), experiments in HEK293 cells supported a more subtle role for ERAD in maintaining steady-state levels of KCC2. Nevertheless, this system allowed for an analysis of KCC2 glycosylation in the ER and Golgi, which serves as a read-out for transport through the secretory pathway. In turn, KCC2 was remarkably stable in primary rat neurons, suggesting that KCC2 folds efficiently in more native systems. Consistent with these data, the mature glycosylated form of KCC2 was abundant in primary rat neurons as well as in rat and human brain. Together, this work details the first insights into the influence that the cellular and membrane environments have on several fundamental KCC2 properties, acknowledges the advantages and disadvantages of each system, and helps set the stage for future experiments to assess KCC2 in a normal or disease setting.
神经元特异性 K+/Cl−协同转运蛋白 2(KCC2)对于大脑发育至关重要,它调节γ-氨基丁酸(GABA)依赖的抑制性神经传递。与它的功能一致,KCC2 中的突变与神经发育障碍有关,包括癫痫、精神分裂症和自闭症。KCC2 具有 12 个跨膜区,形成一个交织的二聚体。基于其复杂的结构和功能,当编码该蛋白的 SLC12A5 基因中存在特定的疾病相关突变时,已经报道了细胞表面表达和/或活性的降低。这些数据表明,KCC2 可能像其他复杂的多跨离子通道一样固有地不稳定,因此容易受到降解错误折叠蛋白的细胞质量控制途径的影响。为了验证这些假设,我们在五个模型系统中检查了 KCC2 的稳定性和/或成熟度:酵母、HEK293 细胞、原代大鼠神经元以及大鼠和人类脑突触体。尽管酵母研究表明 KCC2 被选择进行内质网相关降解(ERAD),但 HEK293 细胞的实验支持 ERAD 在维持 KCC2 的稳态水平方面发挥更微妙的作用。然而,该系统允许分析 KCC2 在 ER 和高尔基体中的糖基化,这是通过分泌途径运输的读出信号。反过来,KCC2 在原代大鼠神经元中非常稳定,这表明 KCC2 在更自然的系统中有效地折叠。与这些数据一致,成熟的糖基化形式的 KCC2 在原代大鼠神经元以及大鼠和人类脑中丰富。总的来说,这项工作详细介绍了细胞和膜环境对 KCC2 几个基本特性的影响的第一手见解,承认了每个系统的优缺点,并为未来在正常或疾病环境下评估 KCC2 的实验奠定了基础。